The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer
1994 ◽
Vol 30
(11)
◽
pp. 1688-1694
◽
1996 ◽
Vol 19
(6)
◽
pp. 552-557
◽
1993 ◽
Vol 215
(1)
◽
pp. 51-63
◽